Dutton Associates

Dutton Associates was an independent investment research firm that specialized in providing equity analysis for small-cap and micro-cap companies, with a significant focus on the biotechnology and healthcare sectors. Operating on an issuer-paid model, the firm provided detailed research reports, ratings, and price targets to increase the visibility of emerging companies among independent investors. While not a drug developer itself, Dutton Associates was a notable source of third-party analysis for many early-stage life science companies during the early to mid-2000s. The firm is currently considered inactive, as its primary research output ceased over a decade ago.